Skip to content
    CVS Health logo

    CVS Health

    Woonsocket, Rhode Island, United StatesFounded 2021
    www.cvshealth.comLinkedIn
    Healthcare

    CVS Health Ventures is the dedicated corporate venture capital arm of CVS Health, investing in early-stage companies focused on making health care more accessible, affordable, and simpler through technology-enabled innovation and digital health.

    71% of their portfolio is in Healthcare. Average disclosed round size is $100.6M (across 49 rounds with reported amounts).

    Find people at CVS Health on Goldilocks AI

    Portfolio

    37

    Fund Size

    $100M

    Top Stage

    Series C

    Last 12 Mo

    9

    Team

    AC

    Amy Compton-Phillips, MD

    Executive Vice President and Chief Medical Officer, CVS Health®

    BN

    Brian Newman

    Executive Vice President and Chief Financial Officer, CVS Health®

    ED

    Ed DeVaney

    Executive Vice President and President, Caremark®

    HC

    Heidi Capozzi

    Executive Vice President and Chief People Officer, CVS Health®

    Katerina Guerraz

    Katerina Guerraz

    Executive Vice President, CVS Health and Chief Operating Officer, Aetna and President of Medicaid, Aetna

    LS

    Len Shankman

    Executive Vice President and President, Pharmacy Services, CVS Health®

    PS

    Prem Shah

    Executive Vice President and Group President, CVS Health®

    SK

    Sam Khichi

    Executive Vice President, Corporate Affairs and Chief Legal Officer

    ST

    Siddharth Tenneti

    Senior Vice President and Interim President, Pharmacy and Consumer Wellness

    SC

    Sree Chaguturu, MD

    Executive Vice President and President of Health Care Delivery®

    SN

    Steve Nelson

    Executive Vice President and President, Aetna®

    TM

    Tilak Mandadi

    Executive Vice President, Ventures and Chief Experience and Technology Officer, CVS Health®

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    55 investments
    CompanyRoundAmountDate
    Thyme logoThymeSeries E$125MSep 2026
    Thyme Care logoThyme CareSeries E$125MSep 2026
    Onos Health logoOnos HealthSeries A$17MAug 2026
    Codoxo logoCodoxoSeries C$35MFeb 2026
    Big Health logoBig HealthUnknown$23.7MFeb 2026
    Simile logoSimileSeries B$200MJan 2026
    Simile logoSimileSeries B$200MJan 2026
    Thyme Care logoThyme CareSeries E—Jan 2026
    H1 logoH1Unknown$40MJan 2026
    Codoxo logoCodoxoSeries C—Dec 2025
    Thyme Care logoThyme CareSeries D$97MSep 2025
    Thyme logoThymeSeries D$97MSep 2025
    Amplifai Health logoAmplifai HealthSeries B$33.7MSep 2025
    Strive Health logoStrive HealthSeries D$550MSep 2025
    Strivehealth logoStrivehealthSeries D$550MSep 2025
    EEllipsis Health, Inc.Series A$45MJun 2025
    Kouper Health logoKouper HealthUnknown$10MMay 2025
    Oshi Health logoOshi HealthSeries C$60MJan 2025
    NNema HealthSeries A$14.5MJan 2025
    Nema logoNemaSeries A$14.5MJan 2025
    AbsoluteCare logoAbsoluteCareGrowth$135MJan 2025
    Synapticure logoSynapticureSeries A$25MNov 2024
    Oshi Health logoOshi HealthSeries C—Oct 2024
    Thyme Care logoThyme CareSeries C$95MJul 2024
    Thyme Care logoThyme CareSeries E—May 2024
    Page 1 of 3

    Top Co-Investors

    Frist Cressey Ventures11 shared
    Humana8 shared
    Flare Capital Partners8 shared
    AlleyCorp7 shared
    Oak HC/FT6 shared
    Andreessen Horowitz (a16z) Bio + Health6 shared
    Morgan Health6 shared
    General Catalyst5 shared
    Sequoia Capital5 shared
    FirstMark Capital5 shared
    Concord Health Partners5 shared
    Foresite Capital5 shared
    Bessemer Venture Partners5 shared
    .406 Ventures5 shared
    Y Combinator5 shared
    Redpoint Ventures4 shared
    3L Capital4 shared
    Insight Partners4 shared
    Takeda Ventures, Inc.4 shared
    RA Capital Management4 shared

    Last updated: 7 October 2026